Sonoma pharmaceuticals and microsafe group dmcc announce that u.s. epa has added nanocyn® hospital-grade disinfectant to list n for use against covid-19

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing patented microcyn® technology-based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the microsafe group dmcc, are pleased to announce that nanocyn® hospital grade disinfectant has been added to the list of covid-19 disinfectants m
SNOA Ratings Summary
SNOA Quant Ranking